Pharmacological (PAG) inhibition of CTH on human glioblastoma cells results to lower Glioblastoma Stem Cell (GSC) formation and lower mRNA expression of stem cell markers (i.e, PROM1, NOX4). This evidence concerns the gene NOX4 and glioblastoma.